SCHEMBL23784378

SCHEMBL23784378

COc1cc2c(cc1OCCCN1CCCC1)[nH]c1cc(O)ncc12

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EHMT2 Q96KQ7 9/20 0.51
▸ EHMT1 Q9H9B1 8/20 0.51
▸ KDM4E B2RXH2 2/20 0.51
▸ ALDH1A1 P00352 2/20 0.51
▸ HSD17B10 Q99714 2/20 0.51
▸ ALOX15 P16050 1/20 0.51
▸ KMT2A Q03164 1/20 0.51
▸ SPIN1 Q9Y657 3/20 0.49
▸ TLR9 Q9NR96 2/20 0.46
▸ TLR7 Q9NYK1 2/20 0.46
▸ KIT P10721 2/20 0.46
▸ PLK4 O00444 1/20 0.46
▸ GAK O14976 1/20 0.46
▸ EPHB6 O15197 1/20 0.46
▸ RIPK2 O43353 1/20 0.46
▸ ERN1 O75460 1/20 0.46
▸ STK10 O94804 1/20 0.46
▸ MAP4K4 O95819 1/20 0.46
▸ CHEK2 O96017 1/20 0.46
▸ ABL1 P00519 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Formic Acid SCHEMBL20580538 0.95 KDM4E (0.49) EHMT2EHMT1KDM4EALDH1A1HSD17B10
SCHEMBL23784367 0.88 EHMT2 (0.52) EHMT2EHMT1KDM4EALDH1A1HSD17B10
SCHEMBL23784349 0.87 EHMT2 (0.49) EHMT2EHMT1KDM4EALDH1A1HSD17B10
Hydrochloric Acid SCHEMBL20581101 0.87 EHMT2 (0.51) EHMT2EHMT1KDM4EALDH1A1HSD17B10
SCHEMBL20581138 0.87 EHMT2 (0.56) EHMT2EHMT1KDM4EALDH1A1HSD17B10
Hydrochloric Acid SCHEMBL20581141 0.86 EHMT2 (0.55) EHMT2EHMT1KDM4EALDH1A1HSD17B10
SCHEMBL23784377 0.84 SPIN1 (0.51) EHMT2EHMT1SPIN1TLR9TLR7
SCHEMBL20580883 0.84 EHMT2 (0.55) EHMT2EHMT1SPIN1KITPLK4
Hydrochloric Acid SCHEMBL20581331 0.83 SPIN1 (0.51) EHMT2EHMT1KDM4EALDH1A1HSD17B10
Hydrochloric Acid SCHEMBL20581131 0.83 EHMT2 (0.54) EHMT2EHMT1KDM4EALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3634962-B1 AZAINDOLE COMPOUNDS AS HISTONE METHYLTRANSFERASE INHIBITORS GLOBAL BLOOD THERAPEUTICS INC (US) 2023-05-24 — — EP disclosed
US-20210371417-A1 AZAINDOLE COMPOUNDS AS HISTONE METHYLTRANSFERASE INHIBITORS GLOBAL BLOOD THERAPEUTICS, INC. 2021-12-02 — — US disclosed
US-11111243-B2 Azaindole compounds as histone methyltransferase inhibitors GLOBAL BLOOD THERAPEUTICS, INC. (US) 2021-09-07 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11111243-B2 Azaindole compounds as histone methyltransferase inhibitors EHMT2, EHMT1, EZH2 EHMT2 1/4885EHMT1 2/4885KDM4E 73/4885
US-20210371417-A1 AZAINDOLE COMPOUNDS AS HISTONE METHYLTRANSFERASE INHIBITORS EHMT2, EHMT1, EZH2 EHMT2 1/4885EHMT1 2/4885KDM4E 73/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback